The FOXM1 Gene is a gene/protein involved in various cellular processes relevant to neurodegenerative diseases. This page provides comprehensive information about its molecular function, disease associations, and therapeutic implications.
Foxm1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
FOXM1 (Forkhead Box M1) is a transcription factor encoded by the FOXM1 gene located on chromosome 12p13.33[@katoh2004]. It belongs to the forkhead/winged-helix domain-containing transcription factor family, characterized by a conserved DNA-binding domain called the forkhead box (Fox)[@clark1993].
The FOXM1 gene spans approximately 25 kb and contains multiple exons. The FOXM1 protein, which is approximately 664 amino acids in length with a molecular weight of around 82 kDa, consists of several functional domains that work together to regulate gene expression and cellular functions[@laoukili2007].
The FOXM1 Gene is a gene/protein involved in various cellular processes relevant to neurodegenerative diseases. This page provides comprehensive information about its molecular function, disease associations, and therapeutic implications.
Foxm1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
FOXM1 (Forkhead Box M1) is a transcription factor encoded by the FOXM1 gene located on chromosome 12p13.33[@katoh2004]. It belongs to the forkhead/winged-helix domain-containing transcription factor family, characterized by a conserved DNA-binding domain called the forkhead box (Fox)[@clark1993].
The FOXM1 gene spans approximately 25 kb and contains multiple exons. The FOXM1 protein, which is approximately 664 amino acids in length with a molecular weight of around 82 kDa, consists of several functional domains that work together to regulate gene expression and cellular functions[@laoukili2007].
The N-terminal Repressor Domain contains transcriptional repression motifs that interact with co-repressors including histone deacetylases (HDACs). The Forkhead DNA-Binding Domain (FH) is the conserved DNA-binding region of approximately 100 amino acids that recognizes the consensus sequence TAAACA, which is the Fox-binding element. The Transactivation Domain (TAD) is located in the C-terminal region and interacts with co-activators including p300/CBP to enhance transcriptional activity. The Centrosome-Binding Domain mediates localization to centrosomes during mitosis, while the FAZ (Forkhead Association) Domain serves as a protein-protein interaction domain.
FOXM1 functions as a key transcriptional regulator of cell cycle and DNA repair genes, playing essential roles in maintaining cellular homeostasis and responding to cellular stress[@koo2012].
FOXM1 promotes cell cycle progression at multiple checkpoints throughout the cell division cycle. During the G1/S transition, FOXM1 activates the expression of cyclin E, cyclin A, and CDK inhibitors that facilitate passage through this critical restriction point. At the G2/M transition, FOXM1 regulates expression of cyclin B1, CDC25B, and Aurora kinase B, which are essential for entry into mitosis. Regarding mitotic entry, FOXM1 controls mitotic spindle assembly genes including NuMA and TPX2, ensuring proper chromosome alignment and segregation. For chromosome segregation, FOXM1 regulates centromere protein expression to ensure accurate distribution of genetic material to daughter cells.
FOXM1 plays a crucial role in maintaining genomic integrity through regulation of multiple DNA repair pathways. In Nucleotide Excision Repair (NER), FOXM1 regulates expression of XPA, XPC, and TFIIH components that recognize and remove bulky DNA lesions[@tan2015]. For Homologous Recombination (HR), FOXM1 controls BRCA1, BRCA2, and RAD51 expression, which are essential for error-free repair of double-strand breaks. In Base Excision Repair (BER), FOXM1 regulates OGG1 and MYH expression to handle oxidative DNA damage. Regarding the DNA Damage Checkpoint, FOXM1 controls CHK1, CHK2, and p53 activity to coordinate cell cycle arrest with DNA repair.
Beyond cell cycle and DNA repair, FOXM1 influences additional cellular processes that are relevant to neuronal health and disease. FOXM1 promotes cell division in progenitor and stem cells, making it essential for tissue maintenance and regeneration. During neurogenesis, FOXM1 is essential for neural stem cell proliferation and differentiation, supporting brain development and adult neurogenesis. Regarding mitochondrial function, FOXM1 regulates mitochondrial DNA replication and biogenesis to maintain cellular energy production. In angiogenesis, FOXM1 controls VEGF expression in vascular endothelial cells, supporting blood vessel formation and tissue perfusion.
FOXM1 expression exhibits tissue-specific and developmental stage-specific patterns that reflect its roles in development and tissue maintenance[@wu2010].
In the adult brain, FOXM1 is primarily expressed in Subventricular zone (SVZ) neural progenitor cells, Hippocampal dentate gyrus granule cells, and Cerebellar granule cell precursors. This pattern of expression in neural progenitor populations suggests important roles in adult neurogenesis and brain plasticity.
FOXM1 activity is tightly regulated at multiple levels to ensure appropriate responses to cellular signals and maintain tissue homeostasis[@halasi2013].
FOXM1 expression is controlled by several key signaling pathways and transcription factors. The Wnt/β-catenin pathway activates FOXM1 transcription through direct binding of β-catenin to FOXM1 regulatory elements. Sonic hedgehog (Shh) signaling induces FOXM1 expression through Gli proteins that act as transcriptional effectors. The tumor suppressor p53 represses FOXM1 transcription, creating a regulatory link between DNA damage response and cell cycle control. NF-Y, the CCAAT box binding factor, activates FOXM1 transcription through binding to promoter elements.
FOXM1 activity is modulated by several post-translational modifications that affect its stability, localization, and transcriptional activity. Phosphorylation by CDK-cyclin complexes, particularly at threonine 596 and serine 361, activates FOXM1 and promotes its nuclear localization. Acetylation by p300/CBP enhances FOXM1 transcriptional activity by preventing ubiquitination and promoting co-activator recruitment. Ubiquitination by SCF ubiquitin ligase targets FOXM1 for proteasomal degradation, controlling protein turnover. Sumoylation by SUMO conjugation modulates FOXM1 stability and activity in response to cellular stress.
FOXM1 expression is post-transcriptionally regulated by several microRNAs that bind to the FOXM1 3'UTR. The miR-200 family, including miR-200b and miR-200c, directly target FOXM1 to suppress its expression. During neuronal differentiation, miR-134 represses FOXM1 to promote exit from the cell cycle. In cancer and neurological disease contexts, miR-370 targets FOXM1 as part of broader regulatory networks.
FOXM1 plays complex roles in AD pathogenesis through multiple mechanisms that affect neuronal survival and function[@li2008].
FOXM1 influences neuronal cell cycle re-entry in AD, where post-mitotic neurons in the AD brain inappropriately re-enter the cell cycle. FOXM1 overexpression promotes neuronal cell cycle activation, leading to DNA replication stress and ultimately neuronal death. This phenomenon represents a pathological response to cellular stress signals.
Regarding DNA repair deficits, FOXM1-regulated DNA repair genes are downregulated in AD, with reduced expression of XPA, XPC, and BRCA2 observed in the AD hippocampus. The accumulation of DNA damage contributes to progressive neuronal loss in affected brain regions.
FOXM1 is affected by amyloid-β effects, as Aβ42 oligomers suppress FOXM1 expression and Aβ-induced neurotoxicity is partially mediated through FOXM1 inhibition. FOXM1 may protect against Aβ-induced DNA damage through its DNA repair regulatory functions.
With respect to tau pathology, FOXM1 regulates tau phosphorylation via CDK5/p35 signaling, and tau pathology correlates with FOXM1 dysfunction. Therapeutic modulation of FOXM1 may therefore affect tauopathy progression.
FOXM1 alterations are observed in PD models and patients, suggesting roles in dopaminergic neuron survival and disease pathogenesis[@im2016].
FOXM1 deficiency in dopaminergic neurons causes parkinsonian features, with mouse models showing progressive dopaminergic neuron loss when FoxM1 is knocked out. Mitochondrial complex I impairment affects FOXM1 activity, creating a link between mitochondrial dysfunction and FOXM1 regulation in PD.
Regarding mitochondrial dysfunction, the PINK1/Parkin pathway intersects with FOXM1 regulation, and mitophagy defects may relate to FOXM1 downregulation. FOXM1 regulates PGC-1α and mitochondrial biogenesis genes to maintain mitochondrial health.
FOXM1 expression is altered in α-synuclein aggregation models, and FOXM1 may regulate genes involved in protein aggregation. An interaction with Lewy body pathology has been observed in PD brain tissue.
Emerging evidence links FOXM1 to ALS through mechanisms affecting motor neuron survival and disease pathogenesis[@kwok2015].
FOXM1 is expressed in spinal cord motor neurons, and dysregulation is observed in ALS models. FOXM1 may affect DNA repair capacity in motor neurons, which could influence disease progression.
Regarding C9orf72 hexanucleotide repeat disease mechanisms, FOXM1 may interact with C9orf72 pathology, and DNA damage response alterations are observed in C9orf72-ALS.
With respect to oxidative stress, FOXM1 regulates antioxidant gene expression, and reactive oxygen species (ROS) can modulate FOXM1 activity. These findings have implications for understanding sporadic ALS pathogenesis.
FOXM1 involvement in HD has been demonstrated through several lines of evidence[@sheikh2019].
Mutant huntingtin affects FOXM1 transcriptional activity, leading to altered expression of FOXM1 target genes in HD models. Cell cycle dysregulation in HD pathogenesis may be partially mediated through FOXM1 dysfunction.
Regarding DNA repair, FOXM1-controlled DNA repair genes are affected in HD, and base excision repair defects may relate to FOXM1 dysfunction. The therapeutic potential of FOXM1 modulation in HD is being investigated.
FOXM1 interacts with various proteins relevant to neurodegeneration through distinct interaction domains and mechanisms[@wang2010]. These interactions shape FOXM1's transcriptional activity and localization within cells.
FOXM1 represents a potential therapeutic target for neurodegenerative diseases through multiple mechanisms of intervention[@zhou2020].
DNA repair enhancement through small molecule activators of FOXM1 could enhance DNA repair capacity in neurons. Gene therapy approaches to increase FOXM1 expression are being explored, along with strategies for normalizing the cell cycle in neurons where inappropriate re-entry occurs.
Cell cycle modulation represents another therapeutic strategy, focusing on preventing inappropriate neuronal cell cycle re-entry through CDK inhibitors that affect FOXM1 phosphorylation. Selective targeting in affected neuronal populations is essential for avoiding unwanted effects.
For neuroprotection, FOXM1 induction represents a potential neuroprotective strategy that could be combined with other neuroprotective approaches. Enhancement of mitochondrial function through FOXM1 regulation may provide additional benefits.
Several challenges remain for FOXM1-targeted therapies, including the oncogenic properties of FOXM1 that raise cancer risk concerns with systemic activation. Tissue-specific delivery systems are needed, and balancing cell cycle effects in neurons versus proliferation in other cell types requires careful consideration.
Various experimental models are used to study FOXM1 to understand its normal functions and disease relevance[@korfi2016].
Knockout mice have been generated, with FoxM1-/- mice being embryonic lethal, while neural-specific knockouts are available for studying brain functions. Conditional knockouts using inducible systems enable studies of adult brain functions without developmental effects. Transgenic reporter lines allow visualization of FOXM1 activity in living tissues. iPSC models derived from patient iPSCs provide human neurons for studying FOXM1 in disease contexts. CRISPR-Cas9 gene editing enables precise manipulation of FOXM1 for functional studies.
The study of Foxm1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
The following diagram shows the key molecular relationships involving FOXM1 Gene discovered through SciDEX knowledge graph analysis: